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Abstract
Background—Although many studies conducted among American Indian and Alaska Native 
(AI/AN) populations may help to advance medical science and lead to improvements in health and 
health care, historically few have endeavored to share their findings, benefits, and/or expected 
outcomes with the communities in which they are conducted. This perceived lack of 
responsiveness has contributed to a perception in some AI/AN communities that researchers are 
disrespectful and may not make community needs a priority.
Objectives—In the context of a study assessing the care received by AI/AN men with incident 
elevated prostate-specific antigen (PSA) levels, this paper describes our experience building 
collaborative relationships, planning, conducting analyses, and disseminating findings with four 
AI/AN communities.
Methods—We established formal partnerships with three Northern Plains AI communities and 
one AN tribal health organization, convened a 12-member Community Advisory Board (CAB), 
and obtained study approvals from all necessary tribal and institutional review bodies before 
implementing our study. A menu of options for study implementation was given to key 
collaborators at each site. CAB members and collaborating tribes contributed to each phase of the 
study. After data analysis, results were shared with tribal and institutional leaders.
Lessons Learned—Face-to-face communication, flexibility, and adaptability, as well as clearly 
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Conclusions—This study demonstrates the importance and feasibility of forging collaborative 
relationships with AI/AN community leaders in regions of Alaska and the Northern Plains in 
cancer control initiatives for AI/AN men.
Keywords
Community-based participatory research; community health partnerships; urogenital neoplasms; 
health care quality and access
Past research involving Native American communities has been promoted as an effort to 
improve health status.1 However, despite cooperation and participation in research studies, 
AI/AN people have continued to have significant health disparities and negative feelings 
about past research.1–6 Historically, although many studies conducted in these populations 
may have helped to advance medical science and aimed to eventually improve health and 
health care, few have endeavored to share their findings, benefits, and/or expected outcomes 
with the AI/AN communities in which they were conducted.1,7 This perceived lack of 
responsiveness to community concerns has contributed to negative perceptions of research 
in some AI/AN communities. Unethical research practices and misuse of participant 
information and data have further contributed to a generalized distrust of research in many 
Native communities.8
Community-based participatory research (CBPR) has been endorsed by AI/AN advocates, 
tribal leaders, and researchers9,10 as an approach that honors community priorities and 
engages community representatives as equal partners in all aspects of the research process, 
from defining the research question to the interpretation and dissemination of research 
results.1,7 CBPR also has been implemented as a means of developing local research 
capacity and increased local ownership of health and health care problems and their 
solutions.11
In late 2007 and early 2008, the U.S. Centers for Disease Control and Prevention (CDC) 
initiated a Request for Applications (RFA 2008-R-15) through the Potential Extramural 
Project program. Concerned about health disparities, researchers at the CDC wanted to 
assess the feasibility of a study that would identify AI/AN men with elevated PSA levels and 
document the patterns of diagnosis and clinical follow-up for the affected men. Because of 
the extant literature, it was clear that a CBPR approach would be a desirable methodology 
for this activity. The RFA also required a dissemination plan for translation of results back 
to communities.
Mayo Clinic’s relationships with AI/AN tribes and organizations extend back to 
collaborations in Alaska that began in 1963 (Anne Lanier, personal communication), and to 
formal outreach, training, education, and infrastructure development programs,12–14 
focusing in the Northern Plains that began in the mid-1990s.15,16 These programs originally 
launched when tribes in the Aberdeen Indian Health Service (IHS) Area requested assistance 
in developing breast and cervical cancer screening programs.
In 2006, Mayo Clinic and the Department of Health and Human Services/IHS signed a 
memorandum of understanding (MOU). The MOU addressed five areas designed to improve 
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tribal health: Cost-effective health care, research, education, grants and funding, and 
professional development, and intended that all initiatives reflect partnership and mutual 
benefit.
In this context, and around the same time as the CDC RFA was issued, several tribal 
organizations with which our team had established relationships had identified men’s cancer 
issues as an unaddressed need. A team from Mayo Clinic regularly attends standing 
meetings of the Minnesota tribal health directors and actively collaborates with the Alaska 
Native Medical Center. When the research opportunity arose, we initiated a conversation 
with several tribal health and IHS leaders to inform them of the opportunity to launch a 
collaborative, federally funded assessment of prostate care in their clinics and hospitals and 
invited tribes who were interested to discuss their level of interest further with us. Several 
representatives expressed interest. Most were motivated by a desire to demonstrate they 
were pursuing men’s health issues in their communities and saw participating in this project 
as a tangible means of achieving that objective. Of the original six communities who 
expressed an interest, four went on to partner with us once funding was obtained and as the 
study commenced. Both the CDC and the tribal representatives wanted to use CBPR 
principles pragmatically to optimize the possibility of sustained community empowerment 
and change occurring even from a small, retrospective study.
In a context of cultivating strong, trusting, working relationships, we worked with our 
partners and CAB to design and carry out a study that captured theoretically and practically 
the essence of the CBPR definition: “a collaborative approach that equitably involves … 
community members, organizational representatives, and researchers in all aspects of the 
research process.”11 Whereas the primary CDC objective was to assess the feasibility of 
conducting a CBPR-based study involving AI/AN communities and to describe patterns of 
care after a newly elevated PSA, we also sought to respond to the needs and interests of 
tribal community priorities. Herein, we have described our experience in planning and 
conducting these analyses and disseminating results to community partners.
METHODS
Consistent with the CDC objectives, we and our partners established three specific aims 
related to the patterns of follow-up care received by AI/AN men who had an incident PSA 
elevation at some point between January 1, 2006, and May 31, 2009: (1) Describe 
demographic, clinical, and service use characteristics, (2) assess patient-report experiences 
and outcomes of care, and (3) Identify “lessons learned.”
Formation of Community Partnerships
After preliminary contact with tribal health directors and other key stakeholders at several 
locations in Minnesota and one in Alaska, we ultimately established formal partnerships 
with three Northern Plains AI communities and one AN tribal health organization. In 
numerous subsequent conversations, both in person and over the phone, we jointly discerned 
how best to fit the draft research objectives and proposed timelines (which originated with 
the CDC and Mayo Clinic) with the practical needs and limitations of the communities in 
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which the study would be conducted. A brief overview of our community partnership 
process is shown in Figure 1.
The formation and initial meeting of our 12-member CAB was an important first step in this 
process, both as a means of gathering representatives from each community under one roof 
and setting a tone of collegiality and teamwork that we hoped would facilitate frank 
discussion among partnering community members, health care providers, and academic 
researchers. Topics in our discussions included potential barriers to study implementation, 
suggested ways to overcome those barriers, and ideas about which issues related to an 
elevated PSA test and follow-up care among AI/AN populations were most relevant and 
important to address in the study. After this first face-to-face meeting, our research team 
sent electronic updates to CAB members on study progress at regular intervals. This initial 
feedback was supplemented with on-site visits to each of our partnering facilities to 
ascertain their specific needs and preferences regarding sampling, methodology, personnel, 
and research approval.
Obtaining Study Approval in AI/AN Communities
To conduct research within tribal entities, investigators must navigate review processes that 
vary with the tribal organization, but can include review by tribal councils (which have 
many different configurations from a sole “executive branch” to a three-branch 
governmental structure), tribal or IHS institutional review boards (IRBs), tribal health 
departments, and various committees. In some instances separate MOUs must be drafted and 
signed. In nearly all cases, investigators must obtain tribal resolutions authorizing the 
research in addition to IRB approval from their academic institution. If research involves an 
IHS facility, staff, or patients, the investigators must also obtain reviews by area and 
national IHS review boards. Researchers who engage tribes must incorporate substantial 
time in their planning and study implementation for obtaining the necessary approvals and 
designing collaborative processes into their study protocols.
Before study implementation and while initial conversations were being held with 
community partners, we began obtaining the required IRB and/or tribal approvals from 
partnering sites and other relevant institutions such as the National IHS IRB. Approval was 
first sought and granted by the Mayo Clinic IRB. Protocols for the Mayo and National IHS 
IRBs were written generally to allow us flexibility to account for varied tribal expectations, 
requirements, and capacities for participation.
These tribe-specific characteristics impacted both how the study would be implemented and 
data collected, leading to study protocols specific to the circumstances in each of our four 
partnering communities but within the constraints of IHS and Mayo Clinic IRB 
requirements. In two communities, no formal protocol submission was required because our 
project was introduced by their Tribal Health Director, discussed by the Tribal Council, and 
eventually approved for implementation by unanimous vote. Two other communities with 
formal tribal approval processes had specific application processes, one of which was 
multistep and required initial “concept proposal” approval by an institutional committee 
before protocol submission to their area IRB. Upon IRB approval, several other institutional 
and committee reviews and approvals were needed for study implementation to commence 
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at that particular site. Timing of each submission at this partnering site was important, 
because missing a deadline date for one tribal review committee could delay submission to 
another. Approximately 1 year was devoted to the approval process for the four sites.
Data Collection Approach
Participants at each of our three partnering sites in Northern Minnesota were enrolled 
members of tribes where on-reservation care was available, whereas participants in Alaska 
resided in a geographically defined region surrounding a medical center that provides 
comprehensive medical services for AI/AN people living in Alaska. Early in the 
implementation phase, we developed a flexible data collection process that reflected site 
resource capacity and preferences. In Alaska, we used a subcontract to pay research nurses 
and other staff at the partnering facility to conduct all facets of data collection—both 
medical record reviews and personal interviews. In Minnesota, we blended modes of data 
collection using members of the Mayo research team or on-site staff depending on interest 
and overall staff capacity. At these three sites, the Mayo Clinic team, in collaboration the 
Great Lakes Inter-Tribal Epidemiology Center, collected all medical record data with the 
assistance and oversight of local tribal medical records, clinical, and information technology 
staff.
Specific Aim 1—Reviewed medical records in our study came from men who were (1) 
receiving or had ever received care at one of the four partnering sites, (2) between the ages 
of 50 and 80 years (inclusive) at the time of the medical record search, and (3) had a 
documented PSA test result greater than or equal to 4.0 ng/mL17–19 in laboratory databases. 
We further limited our cohort to those men whose PSA elevation was incident (i.e., no 
documented evidence of prior elevations) and occurred between January 1, 2006, and May 
31, 2009.
We followed a similar methodological approach to Nepple and associates.20 Given the 
largely indolent nature of prostate cancer, and adapting their approach to the care delivery 
context of AI/AN men,20 we decided that follow-up care received at or before 90 days 
would be considered “timely.” Using electronic medical records and paper records when 
available, a team of two (in Alaska, research nurses on staff at the medical center) or three 
(in Minnesota, two members of the Mayo study team and one epidemiologist from the Great 
Lakes Inter-Tribal Epidemiology Center) medical record abstractors manually collected 
basic demographics, insurance status, veteran status, and patterns of care using a standard 
chart abstraction instrument designed for the study. This instrument was a Microsoft Access 
database that was developed in collaboration with a research nurse and computer 
programmer in Alaska. This research nurse, with extensive prior experience conducting 
medical record reviews, was one of the two abstractors assisting with medical record review 
in Alaska and therefore had a vested interest in creating a user-friendly, comprehensive tool.
Patterns of care information collected during the medical record review included the timing, 
frequency, and nature of medical appointments after the elevated PSA test (i.e., records of 
both in-house and outside referrals), modes of communication between patient and provider 
(where present), the presence of comorbidities (only those used in Charlson index21 
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calculations), and treatments and/or medications prescribed in response to the PSA 
elevation. We also ascertained the primary indication for performing the PSA test: (1) 
Screening test for prostate cancer, (2) lower urinary symptoms, or (3) use within the context 
of prevalent benign prostatic hyperplasia or acute prostatitis. All data were double-entered 
into the Microsoft Access database. Any discrepancies between information recorded by the 
data abstractors were resolved by consensus or, if necessary, a third-party clinician 
adjudicated by consulting the medical record.
Specific Aim 2—For the second aim of the study, we developed a semistructured 
interview guide designed to examine key dimensions of men’s experience related to follow-
up care after elevated PSA, including general health, prostate care, mediators (including 
processes), doctor and patient roles, trust in medical profession, outcomes (e.g., quality of 
life/satisfaction), barriers, personal circumstance, institutional conditions, and 
demographics. The domains of doctor and patient role and trust in the medical profession 
were administered in a closed-ended fashion using existing survey measures.
With the same list of eligible patients used for the medical record review, staff at each of our 
collaborating sites contacted (by phone at Minnesota sites; in the clinic at Alaska) each 
eligible patient, inviting them to participate in an interview. A modest cash incentive was set 
($25–$50) and offered by each site to defray time and travel expenses. Even when the Mayo 
Clinic team was asked to play a strong role in study implementation, we sought to build 
capacity and, where possible, train on-site staff for the role of interviewer. Two Minnesota 
partnering sites elected to have staff from the Mayo Clinic team conduct interviews and one 
opted to use local staff trained by members of the Mayo team. On-site interviewers were 
also trained by Mayo staff in Alaska.
On-site staff attempted to obtain interviews from all eligible men, contacting them up to 
three times. Interviews were audio-recorded and followed the script of the interview guide. 
To ensure confidentiality, audio files were stored on a secure electronic server at Mayo 
Clinic and were transcribed anonymously by a trained transcriptionist. Transcriptions were 
proofread and de-identified before analysis.
Data Analysis and Interpretation
Once all data from the medical record review and interview portions of the study had been 
collected, de-identified, and analyzed, we approached our primary contacts at each 
partnering site to discuss refinements to our data analysis approach and establish next steps 
for disseminating preliminary results to tribal leadership. Key contacts at each partnering 
site determined the venue, presentation format, and audience. Preliminary results were 
returned via brief, face-to-face, informal presentations in the fall of 2010 with tribal health 
leaders at each of our partnering sites. In September 2010, we also presented preliminary 
descriptive results to members of our CAB. From this session and other meetings with tribal 
partners, we were able to further refine our analyses.
When data analyses were complete (summer/fall of 2011), Mayo staff re-contacted tribal 
health leaders and collaborators in Minnesota and Alaska to ascertain their preferred mode 
of learning about study findings. At two of three Minnesota sites, Mayo study team 
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members gave formal, in-person presentations to tribal health leaders. At all Minnesota sites, 
the Mayo study team sent a one-page article summarizing the study’s purpose, findings, and 
implications for the future, and encouraged collaborators to disseminate the document in 
community newspapers or clinic newsletters as they deemed appropriate. Out of these 
relationships, we were also invited to return to one clinic to conduct a professional 
development workshop in September of 2011 on screening for prostate cancer. We also 
provided each of our collaborators with an executive summary document detailing study 
findings specific to their site. In Alaska, Mayo staff presented a summarized version of 
results particularly related to study aim 1 at a medical grand rounds lecture. We continue to 
be in contact with these communities and are actively considering collaborative research 
projects even more focused on men’s health priorities.
LESSONS LEARNED
In the process of conducting this pilot study, our research team learned a number of 
important lessons about conducting research in a unique community-based context involving 
sovereign tribal governments, many of which are similar to those listed in Burhansstipanov 
and colleagues.1 In their work, Burhansstipanov and colleagues outline eight lessons learned 
while utilizing a CBPR approach to research conducted in tribal communities. Of those, 
“invest time to create the partnership” (lesson one), “create partnerships with leaders who 
have decision-making responsibilities from each organization” (lesson three), “implement 
active, effective communication among all CBPR partners” (lesson five), and “modify 
standardized evaluation procedures to be culturally acceptable and respectful of the local 
community” (lesson seven) especially resonated with our experience and the resulting 
lessons learned. For our study, we grouped these lessons into the overriding categories of 
communication and flexibility, roles and responsibilities, and challenges and limitations.
Communication and Flexibility
Among the many lessons learned throughout our process of study development and 
implementation, perhaps the greatest related to several aspects of communication and 
maintaining flexibility in our approach. We briefly describe several specific lessons learned 
pertaining to these areas.
First, there is no substitute for face-to-face interaction. No other mode of communication 
was as efficient and effective a means of fostering fruitful conversations about study-related 
details and maintaining momentum for the project. In some cases, email was the simplest 
and fastest mode of communicating with collaborators to assess study progress—particularly 
CAB members, most of whom reside and work in geographically distant locations. 
However, we found that taking the time to travel to partnering sites, meet face to face with 
individuals who were assisting with study implementation, and personally interact with 
partners provided the needed impetus for accomplishing study goals. It also helped the 
researchers to better understand the context in which prostate follow-up care was taking 
place and enabled community partners to participate directly in the research process.
Second, implementing this study required flexibility and adaptability on the part of both 
researchers and community partners. Researchers learned to adapt their approach to fit the 
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environment in which data collection was taking place. In our study, this played out in our 
development of a “menu” of options that allowed partnering sites to decide how they wanted 
to implement the interview aim of our study, described in subsequent paragraphs below. 
Flexibility and adaptability were also important characteristics of community partners, who 
were working with “outsiders” unfamiliar with their systems and who were also likely to 
have other competing priorities, which may have limited the amount of time and degree of 
assistance they could provide to researchers. At one study site, for example, we faced the 
challenge of recruiting an individual to assist with participant interviews, which meant time 
away from the employee’s “regular” work. This employee’s supervisor was amenable to his 
involvement, however, noting the experience would benefit the employee, the study, the 
organization, and the community as a whole.
Discussions among CAB members at our initial meeting proved invaluable in our process of 
discerning how best to design the study in a sufficiently flexible and respectful manner 
given the differences in environment, staffing, resources, and priorities of our partners. This 
was particularly true in discussions surrounding aim 2 of the study in which we proposed to 
gather patient-reported data about men’s experiences after their newly elevated PSA. 
Engaging in extended discussions about the most appropriate means of implementing study 
aim 2 was crucial to its ultimate success.
At the suggestion of CAB members, we ultimately incorporated a “menu” of these and 
similar options for study implementation into our study protocol. This menu included a table 
of options with their associated pros and cons in the following topic areas: (1) What modes 
of data collection should be used? (in-depth interview, focus groups, or a survey); (2) where 
should these data be collected? (at the clinic, in the home, over the telephone, at a health 
fair); (3) who should collect the data? (Mayo research staff, Great Lakes Inter-Tribal 
Epidemiology Center staff; AI/AN research interns, staff on site, students from the 
University of Minnesota—Duluth); (4) how should eligible participants be identified? 
(generate list from electronic medical records, convenience sample); and (5) how should 
eligible participants be invited to participate? (mailing and/or phone call from study team, 
mailing and/or phone call from study site, posters, recruit from in-clinic appointment lists).
This menu of options was incorporated into study protocols at each partnering site. It was 
also used to initiate conversations with key contacts at those sites as phone calls and face-to-
face meetings were scheduled to finalize details of study implementation. In our experience, 
using menus provided the right balance of concrete specificity to which a busy health 
director could react while preserving tribal control over study implementation. Menus also 
illustrate the broader lessons related to flexibility and adaptability that proved necessary to 
maintain project momentum and progress.
Roles and Responsibilities
Conducting CBPR in AI/AN communities may mean tribal partners choose to take an active 
role in all phases of the study or delegate to researchers the primary responsibility for 
executing the study. We came to appreciate both the benefits and challenges of varied levels 
of tribal involvement. The process of data collection can be facilitated and smoothed when 
local members are involved, but if a tribe is small or community members (including local 
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study staff) are well known to each other, potential privacy and confidentiality concerns can 
arise. Tribal partners may opt to have the outside researchers collect all data, as was the case 
in three of our four partnering communities, a preference that preserved participant 
anonymity and diminished the perception that personal health information of participating 
men might be revealed. This approach raises other challenges related to capacity building 
(e.g., a less empowered role of local partners may translate into less potential research 
personnel capacity), but is ultimately responsive to a tribe’s sovereignty and community 
members’ concerns over privacy and confidentiality.
Throughout the study, the research team was constantly reminded that tribal representatives 
work for their people and not for the researchers. This meant that timelines and 
implementation plans may need to be negotiated, but they were ultimately under tribal 
control. Delays in study implementation may also occur as tribal priorities are considered by 
authorizing bodies. This reality called for researchers to anticipate delays and identify 
personnel who could either predict which tribal processes might lead to delays or otherwise 
facilitate forward progression of the project. In this respect, flexibility combined with 
persistence characterized successful phases of study implementation.
Notwithstanding these concerns, in our experience, once a tribal commitment to research 
was made, it was honored. It was therefore essential that researchers respectfully reciprocate 
with the same level of commitment and follow through with disseminating study findings 
once analyses concluded. A violation of that trust would not only harm the current project 
but jeopardize future collaborations, harm institutional reputations, and exacerbate, rather 
than minimize, health disparities. In summary, working with tribes requires researchers to 
work alongside tribal representatives, maintain open lines of communication, and be 
adaptable in their approach.
Challenges and Limitations
We were able to complete our study in a manner that met the objectives of the funding 
agency and was simultaneously responsive to partnering site concerns. Doing so, however, 
was no small task. As would be the case with any community-based study, we encountered 
numerous challenges throughout the processes of study implementation, data collection, data 
analysis, and interpretation and dissemination of findings. Unique to this work, however, 
was the approval process.
Obtaining the required approvals from appropriate tribal research review bodies was a 
complex process. Each of our community partners had its own review processes and 
requirements—some with their own formal IRBs, others without, some with multiple review 
committees, and all with their own unique standards for protocol formatting. Although 
navigating these complex research approval processes was challenging, the process itself 
helped to forge stronger relationships among the collaborators. It also prompted careful 
thought with our community partners about how best to fit the study to the unique 
environments of each community.
Importantly, researchers working with tribal communities must realize that the 
comprehensive nature of research approvals in many AI/AN communities has arisen out of 
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historical missteps on the part of researchers less considerate of AI/AN communities. 
Although specifically responsible for human research protections, the primary obligation of 
IRBs is to ensure human subject protection through compliance with federal regulations and 
the principles of Belmont.22 There are no federal protections for groups or communities, no 
oversight of data ownership agreements, and no assurance that research conducted will 
benefit AI/AN people without formal policies under which research may take place in 
AI/AN communities. Although some IRBs incorporate these policies within their domain, 
others do not and, in some cases, tribal leaders have assumed a direct role oversight. 
Although complex and occasionally time consuming, tribal review and approval provides 
oversight in addition to facilitating researcher access to local communities.
Because our research team was committed to maintaining regular personal contact with 
collaborators at partnering sites and was also responsible for data collection via medical 
record review and personal interviews, travel was a necessary, but often logistically 
challenging and time-consuming component of this study. For those partnering sites who 
chose to use on-site community members in conducting personal interviews with eligible 
men (as part of study aim 2), travel was also required to provide one-on-one instruction and 
interviewer training by members of our research team. Whether more liberal use of 
technology (i.e., video conferencing) would have been (or in the future could be) a suitable 
substitute for travel is unclear.
In addition to these larger strategic concerns, several logistical challenges also hampered 
research implementation. Much advanced planning and coordination were required to ensure 
that all interviews, once recorded and properly labeled, were either uploaded onto a secure 
file transfer protocol site accessible by both members of our research team and community 
partners or mailed to our research team in a timely manner so that transcription and data 
analysis could ensue. At one site, we also faced challenges in retaining study staff. When the 
initial interviewer who had volunteered to assist with study aim 2 unexpectedly left, we were 
faced with the task of identifying another suitable interviewer at that site as well as 
conducting additional on-site training once a replacement was identified. These challenges, 
although by no means unique to conducting research in AI/AN communities, highlight the 
degree of effort necessary to design and implement even a small, retrospective pilot study, 
especially when the study is conducted over great distances.
CONCLUSIONS
Overall, both the process of study implementation and the results of our study itself provide 
evidence of the importance and feasibility of conducting research in AI/AN populations and 
forging lasting, collaborative relationships with key members of these communities. In 
addition to providing some useful pilot data, this project was developed in the context of an 
existing, multi-year MOU between Mayo Clinic and the IHS that was responsive to needs 
and priorities of the IHS and tribes and related to other projects in both regions that were 
launched in response to tribal requests. Thus, the “finding” of a successful partnership 
between an academic medical center, several sovereign tribal organizations, the IHS, and the 
CDC may serve as a foundation upon which future collaborative projects can build to 
incorporate CBPR in a robust way. Funding agencies that promote CBPR projects must be 
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committed to encouraging new researchers to collaborate with tribes, but collaborate in ways 
that suit tribal priorities.23
We believe this study was an important first step in beginning to understand how care is 
delivered to AI/AN men with an elevated PSA as well as in keeping the door open to future 
conversations about this and other research priorities in AI/AN communities.
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